27th Feb 2020 12:15
(Alliance News) - BATM Advanced Communications Ltd said Thursday that its Bio-Medical division has successfully developed a new diagnostics kit to detect the COVID-19 virus.
BATM shares were trading 22% higher in London at 50.10 pence each on Thursday.
The cyber-solutions and biomedical systems provider said this kit has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose coronavirus.
BATM said it has started production of the kit at its Adaltis facility in Rome and is now working with academic and research institutions, mainly in Europe, to make the kit suitable for large scale production.
"The kit, which supports all the [US] Centers for Disease Control & Prevention recommendations, has already received interest from customers in several countries," the company said.
Zvi Marom, chief executive officer, said: "We believe that the strategy we adopted in our Bio-Medical division is proving to be correct, especially in light of the current COVID-19 outbreak. We are able now to quickly provide diagnostic kits for any new pathogen that appears."
By Loreta Juodagalvyte; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Batm Advanced